# 18F-DOPA-PET in Planning Surgery in Patients With Gliomas

> **NCT02020720** · EARLY_PHASE1 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 72 (actual)

## Conditions studied

- Malignant Glioma
- Recurrent Brain Neoplasm

## Interventions

- **PROCEDURE:** Biopsy
- **PROCEDURE:** Computed Tomography
- **PROCEDURE:** Diffusion Weighted Imaging
- **DRUG:** Fluorine F 18 Fluorodopa
- **OTHER:** Laboratory Biomarker Analysis
- **PROCEDURE:** Perfusion Magnetic Resonance Imaging
- **PROCEDURE:** Positron Emission Tomography
- **PROCEDURE:** Therapeutic Conventional Surgery

## Key facts

- **NCT ID:** NCT02020720
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01-22
- **Primary completion:** 2019-10-25
- **Final completion:** 2024-01-10
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2025-01-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02020720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02020720, "18F-DOPA-PET in Planning Surgery in Patients With Gliomas". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02020720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*